|
1
|
Harvey JA, Mirza SA, Erwin PJ, Chan AW,
Murad MH and Brewer JD: Recurrence and mortality rates with
different treatment approaches of Merkel cell carcinoma: A
systematic review and meta-analysis. Int J Dermatol. 61:687–697.
2022.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Perez MC and Zager JS: Aso author
reflections: Resection margins in merkel cell carcinoma: Is a 1 cm
margin wide enough? Ann Surg Oncol. 25 (Suppl
3)(S901)2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Toker C: Trabecular carcinoma of the skin.
Arch Dermatol. 105:107–110. 1972.PubMed/NCBI
|
|
4
|
Paulson KG, Park SY, Vandeven NA, Lachance
K, Thomas H, Chapuis AG, Harms KL, Thompson JA, Bhatia S, Stang A
and Nghiem P: Merkel cell carcinoma: Current US incidence and
projected increases based on changing demographics. J Am Acad
Dermatol. 78:457–463.e2. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Schadendorf D, Lebbe C, Zur Hausen A,
Avril MF, Hariharan S, Bharmal M and Becker JC: Merkel cell
carcinoma: Epidemiology, prognosis, therapy and unmet medical
needs. Eur J Cancer. 71:53–69. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rollison DE, Giuliano AR and Becker JC:
New virus associated with merkel cell carcinoma development. J Natl
Compr Canc Netw. 8:874–880. 2010.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Bichakjian CK, Olencki T, Alam M, Andersen
JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC,
et al: Merkel cell carcinoma, version 1.2014. J Natl Compr Canc
Netw. 12:410–424. 2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Becker J, Mauch C, Kortmann RD, Keilholz
U, Bootz F, Garbe C, Hauschild A and Moll I: Short german
guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges. 6 (Suppl
1):S15–S16. 2008.PubMed/NCBI View Article : Google Scholar : (In English,
German).
|
|
9
|
Doepker MP, Thompson ZJ, Fisher KJ,
Yamamoto M, Nethers KW, Harb JN, Applebaum MA, Gonzalez RJ, Sarnaik
AA, Messina JL, et al: Is a wider margin (2 cm vs. 1 cm) for a
1.01-2.0 mm melanoma necessary? Ann Surg Oncol. 23:2336–2342.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Strom T, Carr M, Zager JS, Naghavi A,
Smith FO, Cruse CW, Messina JL, Russell J, Rao NG, Fulp W, et al:
Radiation therapy is associated with improved outcomes in merkel
cell carcinoma. Ann Surg Oncol. 23:3572–3578. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bichakjian CK, Olencki T, Aasi SZ, Alam M,
Andersen JS, Blitzblau R, Bowen GM, Contreras CM, Daniels GA,
Decker R, et al: Merkel cell carcinoma, version 1.2018, NCCN
clinical practice guidelines in oncology. J Natl Compr Canc Netw.
16:742–774. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shaikh WR, Sobanko JF, Etzkorn JR, Shin TM
and Miller CJ: Utilization patterns and survival outcomes after
wide local excision or mohs micrographic surgery for merkel cell
carcinoma in the United States, 2004-2009. J Am Acad Dermatol.
78:175–177.e3. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Terushkin V, Brodland DG, Sharon DJ and
Zitelli JA: Mohs surgery for early-stage Merkel cell carcinoma
(MCC) achieves local control better than wide local excision +/-
radiation therapy with no increase in MCC-specific death. Int J
Dermatol. 60:1010–1012. 2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yan L, Sun L, Guan Z, Wei S, Wang Y and Li
P: Analysis of cutaneous merkel cell carcinoma outcomes after
different surgical interventions. J Am Acad Dermatol. 82:1422–1434.
2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Schwartz JL, Wong SL, Mclean SA, Hayman
JA, Lao CD, Kozlow JH, Malloy KM, Bradford CR, Frohm ML, Fullen DR,
et al: NCCN guidelines implementation in the multidisciplinary
Merkel cell carcinoma program at the university of Michigan. J Natl
Compr Canc Netw. 12:434–441. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Tai P: A practical update of surgical
management of merkel cell carcinoma of the skin. ISRN Surg.
2013(850797)2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Dellambra E, Carbone ML, Ricci F, Ricci F,
Di Pietro FR, Moretta G, Verkoskaia S, Feudi E, Failla CM, Abeni D
and Fania L: Merkel cell carcinoma. Biomedicines.
9(718)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Singh B, Qureshi MM, Minh TT and Sahni D:
Demographics and outcomes of stage I and II Merkel cell carcinoma
treated with Mohs micrographic surgery compared with wide local
excision in the National cancer database. J Am Acad Dermatol.
79:126–134.e3. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lebbe C, Becker JC, Grob JJ, Malvehy J,
Del Marmol V, Pehamberger H, Peris K, Saiag P, Middleton MR,
Bastholt L, et al: Diagnosis and treatment of Merkel cell
carcinoma. European consensus-based interdisciplinary guideline.
Eur J Cancer. 51:2396–2403. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kinas CG and Carroll BT: General
guidelines for quality assurance of immunohistochemistry in a Mohs
lab. Dermatol Surg. 43:507–511. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Hughes MP, Hardee ME, Cornelius LA,
Hutchins LF, Becker JC and Gao L: Merkel cell carcinoma:
Epidemiology, target, and therapy. Curr Dermatol Rep. 3:46–53.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Garza-Davila VF, Valdespino-Valdes J,
Barrera FJ, Ocampo-Candiani J and Garza-Rodríguez V: Clinical
impact of immunotherapy in Merkel cell carcinoma patients: A
systematic review and meta-analysis. J Am Acad Dermatol.
87:121–130. 2022.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee AY and Berman RS: The landmark series:
Non-melanoma skin cancers. Ann Surg Oncol. 27:22–27.
2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Nghiem P, Bhatia S, Lipson EJ, Sharfman
WH, Kudchadkar RR, Brohl AS, Friedlander PA, Daud A, Kluger HM,
Reddy SA, et al: Durable tumor regression and overall survival in
patients with advanced Merkel cell carcinoma receiving
pembrolizumab as first-line therapy. J Clin Oncol. 37:693–702.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
D'Angelo SP, Bhatia S, Brohl AS, Hamid O,
Mehnert JM, Terheyden P, Shih KC, Brownell I, Lebbé C, Lewis KD, et
al: Avelumab in patients with previously treated metastatic Merkel
cell carcinoma: Long-term data and biomarker analyses from the
single-arm phase 2 JAVELIN Merkel 200 trial. J Immunother Cancer.
8(e000674)2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Topalian SL, Bhatia S, Amin A, Kudchadkar
RR, Sharfman WH, Lebbé C, Delord JP, Dunn LA, Shinohara MM,
Kulikauskas R, et al: Neoadjuvant nivolumab for patients with
resectable merkel cell carcinoma in the checkmate 358 trial. J Clin
Oncol. 38:2476–2487. 2020.PubMed/NCBI View Article : Google Scholar
|
